Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|June 30, 2023
Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trialsYuanfang Li, Shuqiang Yuan, Yingbo Chen, et al.
Cancer Medicine|November 7, 2017
A comprehensive analysis comparing the eighth AJCC gastric cancer pathological classification to the seventh, sixth, and fifth editionsSharvesh Raj Seeruttun, Shuqiang Yuan, Haibo Qiu, et al.
Surgery|July 27, 2015
Time trends of clinicopathologic features and surgical treatment for gastric cancer: Results from 2 high-volume institutions in southern ChinaWei Wang, Chaohui Zheng, Cheng Fang, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 1, 2014
[Changes in clinicopathological features and survival after surgical resection for gastric cancer over a 20-year period at a single institution]Wei Wang, Zhiwei Zhou, Youqing Zhan, et al.
Frontiers in Pharmacology|October 23, 2024
Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patientsZewei Chen, Ruopeng Zhang, Zhoukai Zhao, et al.
Annals of Surgical Oncology|December 2, 2015
Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer PatientsWei Wang, Sharvesh Raj Seeruttun, Cheng Fang, et al.
Annals of Surgical Oncology|May 20, 2015
Incorporation of N0 Stage with Insufficient Numbers of Lymph Nodes into N1 Stage in the Seventh Edition of the TNM Classification Improves Prediction of Prognosis in Gastric Cancer: Results of a Single-Institution Study of 1258 Chinese PatientsBofei Li, Yuanfang Li, Wei Wang, et al.
JAMA Network Open|March 28, 2024
Anti-Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical GastrectomyZhoukai Zhao, Ruopeng Zhang, Guoming Chen, et al.
BMC Cancer|August 28, 2025
Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center studyRuopeng Zhang, Xiaojiang Chen, Guoming Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2020
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II TrialBixia Tang, Zhihong Chi, Yingbo Chen, et al.
Pageof 7